FR2274314B1 - - Google Patents

Info

Publication number
FR2274314B1
FR2274314B1 FR7420376A FR7420376A FR2274314B1 FR 2274314 B1 FR2274314 B1 FR 2274314B1 FR 7420376 A FR7420376 A FR 7420376A FR 7420376 A FR7420376 A FR 7420376A FR 2274314 B1 FR2274314 B1 FR 2274314B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7420376A
Other languages
French (fr)
Other versions
FR2274314A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
METIANU TIBERE
Original Assignee
METIANU TIBERE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by METIANU TIBERE filed Critical METIANU TIBERE
Priority to FR7420376A priority Critical patent/FR2274314A1/en
Publication of FR2274314A1 publication Critical patent/FR2274314A1/en
Application granted granted Critical
Publication of FR2274314B1 publication Critical patent/FR2274314B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7420376A 1974-06-12 1974-06-12 Incorporation of BCG into viral vaccines - in order to increase the immunising power of the vaccine Granted FR2274314A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7420376A FR2274314A1 (en) 1974-06-12 1974-06-12 Incorporation of BCG into viral vaccines - in order to increase the immunising power of the vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7420376A FR2274314A1 (en) 1974-06-12 1974-06-12 Incorporation of BCG into viral vaccines - in order to increase the immunising power of the vaccine

Publications (2)

Publication Number Publication Date
FR2274314A1 FR2274314A1 (en) 1976-01-09
FR2274314B1 true FR2274314B1 (en) 1978-07-21

Family

ID=9139963

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7420376A Granted FR2274314A1 (en) 1974-06-12 1974-06-12 Incorporation of BCG into viral vaccines - in order to increase the immunising power of the vaccine

Country Status (1)

Country Link
FR (1) FR2274314A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms

Also Published As

Publication number Publication date
FR2274314A1 (en) 1976-01-09

Similar Documents

Publication Publication Date Title
FR2313088B1 (en)
FR2269712A1 (en)
FR2277616B3 (en)
FR2277096B1 (en)
FR2273268A1 (en)
JPS50107876A (en)
FR2274314B1 (en)
FR2260027B1 (en)
JPS50109660U (en)
AU8191875A (en)
BG19728A1 (en)
BG21479A1 (en)
BG22527A1 (en)
BG19634A1 (en)
BE837371A (en)
BE832276A (en)
BG19847A1 (en)
BG20217A1 (en)
AU481978A (en)
AU480925A (en)
AU479468A (en)
BG20894A1 (en)
BG20940A1 (en)
BG20951A1 (en)
BG20419A2 (en)

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse